179 related articles for article (PubMed ID: 24078450)
1. TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis.
Ji YN; Wang Q; Xue J
Tumour Biol; 2014 Feb; 35(2):1653-9. PubMed ID: 24078450
[TBL] [Abstract][Full Text] [Related]
2. TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis.
Zhan P; Ji YN; Yu LK
Hepatobiliary Surg Nutr; 2013 Oct; 2(5):260-5. PubMed ID: 24570956
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis.
Zhan P; Ji YN
Hepatobiliary Surg Nutr; 2014 Feb; 3(1):11-7. PubMed ID: 24696834
[TBL] [Abstract][Full Text] [Related]
4. Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.
Liu J; Ma Q; Zhang M; Wang X; Zhang D; Li W; Wang F; Wu E
Eur J Cancer; 2012 Oct; 48(15):2328-38. PubMed ID: 22459764
[TBL] [Abstract][Full Text] [Related]
5. ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
Zhu G; Liao X; Han C; Liu X; Yu L; Qin W; Lu S; Su H; Chen Z; Liu Z; Liang Y; Huang J; Yu T; Yang C; Huang K; Shang L; Ye X; Li L; Qin X; Xiao K; Peng M; Peng T
Oncol Rep; 2017 Sep; 38(3):1451-1463. PubMed ID: 28714006
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
7. Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.
Woo HG; Wang XW; Budhu A; Kim YH; Kwon SM; Tang ZY; Sun Z; Harris CC; Thorgeirsson SS
Gastroenterology; 2011 Mar; 140(3):1063-70. PubMed ID: 21094160
[TBL] [Abstract][Full Text] [Related]
8. Serum VEGF level is associated with the outcome of patients with hepatocellular carcinoma: a meta-analysis.
Zhan P; Qian Q; Yu LK
Hepatobiliary Surg Nutr; 2013 Aug; 2(4):209-15. PubMed ID: 24570945
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis.
Zhan P; Qian Q; Yu LK
Hepatobiliary Surg Nutr; 2013 Jun; 2(3):148-55. PubMed ID: 24570933
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
Zhang Y; Li Y; Jiang W; Li Q; Lan Y
Medicine (Baltimore); 2019 Mar; 98(13):e14810. PubMed ID: 30921182
[TBL] [Abstract][Full Text] [Related]
11. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Qi CY; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():104. PubMed ID: 24548704
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis.
Liu J; Wei Y; Wang T; Zhang Z; Huang H; Wang C; Li H; Jia Q; Wu H; Zou T
Int J Biol Markers; 2020 Dec; 35(4):3-11. PubMed ID: 33208027
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.
Zhang J; Zhang M; Ma H; Song X; He L; Ye X; Li X
Medicine (Baltimore); 2018 Jun; 97(24):e11130. PubMed ID: 29901640
[TBL] [Abstract][Full Text] [Related]
15. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).
Lv X; Ye G; Zhang X; Huang T
Medicine (Baltimore); 2017 Sep; 96(38):e8106. PubMed ID: 28930859
[TBL] [Abstract][Full Text] [Related]
16. Higher expression of cell division cycle-associated protein 5 predicts poorer survival outcomes in hepatocellular carcinoma.
Hou S; Chen X; Li M; Huang X; Liao H; Tian B
Aging (Albany NY); 2020 Jul; 12(14):14542-14555. PubMed ID: 32694239
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis.
Liu J; Li W; Deng M; Liu D; Ma Q; Feng X
PLoS One; 2016; 11(7):e0159636. PubMed ID: 27428001
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
Front Immunol; 2018; 9():2077. PubMed ID: 30254644
[No Abstract] [Full Text] [Related]
19. High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients.
Peng L; Yuan XQ; Zhang CY; Ye F; Zhou HF; Li WL; Liu ZY; Zhang YQ; Pan X; Li GC
Oncotarget; 2017 May; 8(21):34387-34397. PubMed ID: 28415739
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
